Discrepancy between VITEK2 and Etest aminoglycoside susceptibility testing for multidrug-resistant Acinetobacter baumannii

Pathology. 2021 Oct;53(6):805-808. doi: 10.1016/j.pathol.2020.10.021. Epub 2021 Feb 18.

Authors

John Vardanega¹, Raquel Maggacis², Naomi Runnegar³, Patrick N A Harris⁴, Marjoree M Sehu³

Affiliations

¹ Cairns Hospital, Cairns City, Qld, Australia. Electronic address: john.r.vardanega@gmail.com.
² Toowoomba Hospital, South Toowoomba, Qld, Australia.
³ Princess Alexandra Hospital, Woolloongabba, Qld, Australia.
⁴ UQ Centre for Clinical Research, Herston, Qld, Australia; Central Microbiology, Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, Qld, Australia.

PMID: 33612270
DOI: 10.1016/j.pathol.2020.10.021

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Acinetobacter Infections / microbiology*
Acinetobacter baumannii / drug effects*
Aminoglycosides / pharmacology*
Anti-Bacterial Agents / pharmacology*
Disk Diffusion Antimicrobial Tests
Drug Resistance, Bacterial
Humans
Male
Mass Spectrometry
Young Adult

Substances

Aminoglycosides
Anti-Bacterial Agents